ecrin-mdr-crcClinical2016comorbiditycolorectal cancerCancer-Bowel-Back passage (rectum) or large bowel (colon)ComorbidityColorectal CancerCancer-bowel-back Passage (rectum) Or Large Bowel (colon)Interventionalhttps://newmdr.ecrin.org/Study/2462983New Zealand1ECRIN MDRNot yet recruitingfalseA feasibility study: Improving management of comorbidity in patients with colorectal cancerPrimary outcome(s): Proportion of patients with colorectal adenocarcinoma who are approached who consent to enter. This outcome will be assessed by use of a screening log, this will capture all those who are approached and whether they consented to proceed.[At one year after enrolment of first eligible patient];Proportion of patients who consent to enter whom complete screening criterial and fulfil criteria to proceed to CMA This outcome will be assessed by use of a screening log, whether or not a subject proceeds to CMA will be captured as part of the screening log.[one year from enrolment of first eligible patient];Narrative of comorbid conditions identified at CMA[one year from enrolment of first eligible patient] Study Design: Purpose: Treatment; Allocation: Non-randomised trial; Masking: Open (masking not used);Assignment: Single group2016-01-152462983ACTRN12615001312538